| Biological Sciences | 2021-2025 | 8 | CN 2 | 99.99 |
| Medical and Health Sciences | 2021-2025 | 49 | CN 3 | 99.99 |
| Agricultural, Food and Veterinary Sciences | 2021-2025 | 385 | CN 166 | 98.64 |
| Chemistry | 2021-2025 | 679 | CN 305 | 95.72 |
| Molecular Biology | Lifetime | 689 | CN 28 | 99.65 |
| Cancer Research | Lifetime | 111 | CN 3 | 99.41 |
| Surgery | Lifetime | 743 | CN 6 | 99.31 |
| Public, Environmental and Occupational Health | Lifetime | 765 | CN 14 | 98.92 |
| Pulmonary and Respiratory Medicine | Lifetime | 666 | CN 12 | 99.00 |
| Clinical Pharmacology | Lifetime | 314 | CN 5 | 98.69 |
| Complementary and Alternative Medicine | Lifetime | 324 | CN 28 | 98.38 |
| Oncology | Lifetime | 765 | CN 23 | 98.40 |
| Immunology | Lifetime | 789 | CN 20 | 97.45 |
| Pathology and Forensic Medicine | Lifetime | 619 | CN 12 | 97.20 |
| Rheumatology | Lifetime | 722 | CN 10 | 96.33 |
| Food Science and Technology | Lifetime | 954 | CN 117 | 96.10 |
| Ophthalmology | Lifetime | 547 | CN 15 | 93.80 |
| Biotechnology | Lifetime | 534 | CN 34 | 91.07 |
| Immunology and Allergy | Lifetime | 552 | CN 11 | 89.75 |
| Anesthesiology and Pain Medicine | Lifetime | 510 | CN 8 | 87.66 |
| Medical Genetics | Lifetime | 989 | CN 22 | 86.21 |
| Dermatology | Lifetime | 982 | CN 14 | 84.87 |
| Nephrology | Lifetime | 913 | CN 33 | 83.90 |
| Hepatology | Lifetime | 820 | CN 51 | 83.31 |
| Gastroenterology | Lifetime | 688 | CN 17 | 74.28 |
| Internal Medicine | Lifetime | 596 | CN 8 | 58.44 |
| Otolaryngology | Lifetime | 658 | CN 43 | 44.00 |
| Molecular Biology | 2021-2025 | 4 | CN 3 | 99.97 |
| Cancer Research | 2021-2025 | 2 | CN 1 | 99.91 |
| Surgery | 2021-2025 | 38 | CN 1 | 99.78 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 34 | CN 4 | 99.86 |
| Clinical Pharmacology | 2021-2025 | 15 | CN 1 | 99.11 |
| Immunology | 2021-2025 | 40 | CN 8 | 99.15 |
| Oncology | 2021-2025 | 105 | CN 11 | 99.37 |
| Epidemiology | 2021-2025 | 144 | CN 16 | 99.07 |
| Complementary and Alternative Medicine | 2021-2025 | 48 | CN 11 | 98.16 |
| Pathology and Forensic Medicine | 2021-2025 | 75 | CN 5 | 98.35 |
| Public, Environmental and Occupational Health | 2021-2025 | 253 | CN 10 | 97.81 |
| Rheumatology | 2021-2025 | 107 | CN 2 | 97.59 |
| Medical Physiology | 2021-2025 | 277 | CN 15 | 96.29 |
| Food Science and Technology | 2021-2025 | 226 | CN 85 | 96.98 |
| Radiology, Nuclear Medicine and Imaging | 2021-2025 | 321 | CN 30 | 93.63 |
| Plant Science | 2021-2025 | 490 | CN 159 | 94.32 |
| Nutrition and Dietetics | 2021-2025 | 236 | CN 78 | 92.21 |
| Anesthesiology and Pain Medicine | 2021-2025 | 65 | CN 4 | 90.75 |
| Biotechnology | 2021-2025 | 99 | CN 27 | 89.24 |
| Nephrology | 2021-2025 | 234 | CN 20 | 85.42 |
| Organic Chemistry | 2021-2025 | 621 | CN 231 | 83.16 |
| Neuroscience of Neurology | 2021-2025 | 284 | CN 36 | 81.32 |
| Genetics | 2021-2025 | 648 | CN 48 | 80.60 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 970 | CN 51 | 78.77 |
| Ophthalmology | 2021-2025 | 293 | CN 11 | 79.07 |
| Cellular and Molecular Neuroscience | 2021-2025 | 278 | CN 28 | 75.57 |
| Gastroenterology | 2021-2025 | 195 | CN 7 | 77.14 |
| Hepatology | 2021-2025 | 324 | CN 28 | 75.70 |
| Cancer-related molecular mechanisms research | Lifetime | 39 | CN 15 | 99.73 |
| Circular RNAs in diseases | Lifetime | 23 | CN 9 | 99.69 |
| Ferroptosis and cancer prognosis | Lifetime | 18 | CN 5 | 99.55 |
| MicroRNA in disease regulation | Lifetime | 58 | CN 14 | 99.67 |
| RNA modifications and cancer | Lifetime | 160 | CN 12 | 99.51 |
| Extracellular vesicles in disease | Lifetime | 73 | CN 19 | 99.01 |
| Traditional Chinese Medicine and Integrative Care | Lifetime | 33 | CN 25 | 97.19 |
| Cancer, Lipids, and Metabolism | Lifetime | 280 | CN 5 | 98.84 |
| Corneal Surgery and Treatments | Lifetime | 120 | CN 3 | 98.86 |
| Ocular Surface and Contact Lens | Lifetime | 177 | CN 7 | 98.68 |
| Microbial Natural Products and Biosynthesis | Lifetime | 277 | CN 28 | 98.18 |
| Peptidase Inhibition and Analysis | Lifetime | 643 | CN 17 | 97.85 |
| Inflammasome and immune disorders | Lifetime | 266 | CN 17 | 97.36 |
| Fungal Biology and Applications | Lifetime | 472 | CN 92 | 97.21 |
| Immune cells in cancer | Lifetime | 735 | CN 92 | 96.40 |
| Biomarkers in Disease Mechanisms | Lifetime | 131 | CN 6 | 94.88 |
| Cancer-related gene regulation | Lifetime | 873 | CN 119 | 96.16 |
| Protease and Inhibitor Mechanisms | Lifetime | 584 | CN 8 | 96.61 |
| Pancreatitis Pathology and Treatment | Lifetime | 932 | CN 29 | 96.51 |
| Cancer Mechanisms and Therapy | Lifetime | 470 | CN 71 | 95.43 |
| Traditional Chinese Medicine Analysis | Lifetime | 416 | CN 319 | 94.43 |
| Metastasis and carcinoma case studies | Lifetime | 903 | CN 70 | 94.73 |
| Cervical and Thoracic Myelopathy | Lifetime | 395 | CN 18 | 95.71 |
| Marine Sponges and Natural Products | Lifetime | 617 | CN 61 | 95.14 |
| Kruppel-like factors research | Lifetime | 410 | CN 42 | 92.87 |
| Fibroblast Growth Factor Research | Lifetime | 673 | CN 43 | 92.33 |
| Healthcare and Venom Research | Lifetime | 920 | CN 158 | 90.94 |
| Hair Growth and Disorders | Lifetime | 654 | CN 31 | 89.39 |
| Berberine and alkaloids research | Lifetime | 504 | CN 159 | 86.37 |
| Biological and pharmacological studies of plants | Lifetime | 402 | CN 194 | 84.59 |
| Natural Compounds in Disease Treatment | Lifetime | 280 | CN 141 | 82.57 |
| Macrophage Migration Inhibitory Factor | Lifetime | 908 | CN 56 | 80.72 |
| Beetle Biology and Toxicology Studies | Lifetime | 208 | CN 39 | 75.96 |
| Flavonoids in Medical Research | Lifetime | 823 | CN 357 | 76.00 |
| Connective Tissue Growth Factor Research | Lifetime | 635 | CN 74 | 77.35 |
| FOXO transcription factor regulation | Lifetime | 930 | CN 201 | 74.08 |
| Heterotopic Ossification and Related Conditions | Lifetime | 624 | CN 42 | 70.90 |
| Clusterin in disease pathology | Lifetime | 531 | CN 48 | 60.71 |
| Biological Stains and Phytochemicals | Lifetime | 655 | CN 112 | 52.69 |
| RNA modifications and cancer | 2021-2025 | 3 | CN 2 | 99.95 |
| Cancer-related molecular mechanisms research | 2021-2025 | 6 | CN 3 | 99.94 |
| Cell Adhesion Molecules Research | 2021-2025 | 1 | CN 1 | 97.74 |
| Ferroptosis and cancer prognosis | 2021-2025 | 4 | CN 2 | 99.86 |
| Circular RNAs in diseases | 2021-2025 | 7 | CN 3 | 99.74 |
| MicroRNA in disease regulation | 2021-2025 | 14 | CN 9 | 99.71 |
| Epigenetics and DNA Methylation | 2021-2025 | 27 | CN 10 | 98.98 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 13 | CN 2 | 99.64 |
| Inflammasome and immune disorders | 2021-2025 | 15 | CN 6 | 98.85 |
| Cancer-related gene regulation | 2021-2025 | 13 | CN 9 | 98.78 |
| Extracellular vesicles in disease | 2021-2025 | 38 | CN 27 | 98.81 |
| Microbial Natural Products and Biosynthesis | 2021-2025 | 19 | CN 3 | 98.43 |
| Ubiquitin and proteasome pathways | 2021-2025 | 37 | CN 13 | 97.67 |
| Immune Response and Inflammation | 2021-2025 | 37 | CN 11 | 96.54 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 358 | CN 58 | 98.62 |
| RNA Research and Splicing | 2021-2025 | 131 | CN 39 | 96.08 |
| Cancer Genomics and Diagnostics | 2021-2025 | 331 | CN 24 | 97.63 |
| Peptidase Inhibition and Analysis | 2021-2025 | 119 | CN 25 | 97.08 |
| Immune cells in cancer | 2021-2025 | 230 | CN 128 | 95.41 |
| Immune Cell Function and Interaction | 2021-2025 | 412 | CN 100 | 94.99 |
| Marine Sponges and Natural Products | 2021-2025 | 40 | CN 23 | 95.12 |
| Gastric Cancer Management and Outcomes | 2021-2025 | 524 | CN 102 | 95.96 |
| Cancer, Hypoxia, and Metabolism | 2021-2025 | 402 | CN 170 | 91.73 |
| Fungal Biology and Applications | 2021-2025 | 189 | CN 113 | 93.35 |
| Renal cell carcinoma treatment | 2021-2025 | 358 | CN 30 | 94.42 |
| Adipose Tissue and Metabolism | 2021-2025 | 423 | CN 88 | 92.11 |
| Mesenchymal stem cell research | 2021-2025 | 234 | CN 84 | 92.58 |
| Neutrophil, Myeloperoxidase and Oxidative Mechanisms | 2021-2025 | 108 | CN 25 | 90.48 |
| Pancreatic and Hepatic Oncology Research | 2021-2025 | 872 | CN 108 | 94.58 |
| Anesthesia and Pain Management | 2021-2025 | 346 | CN 36 | 92.56 |
| Prostate Cancer Treatment and Research | 2021-2025 | 574 | CN 22 | 95.09 |
| Probiotics and Fermented Foods | 2021-2025 | 454 | CN 199 | 93.24 |
| Spine and Intervertebral Disc Pathology | 2021-2025 | 623 | CN 121 | 93.98 |
| Cancer Cells and Metastasis | 2021-2025 | 436 | CN 89 | 89.68 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | 2021-2025 | 490 | CN 107 | 92.64 |
| Cancer Mechanisms and Therapy | 2021-2025 | 182 | CN 72 | 89.78 |
| Airway Management and Intubation Techniques | 2021-2025 | 228 | CN 8 | 90.41 |
| NF-κB Signaling Pathways | 2021-2025 | 36 | CN 10 | 85.83 |
| Pancreatitis Pathology and Treatment | 2021-2025 | 479 | CN 80 | 91.84 |
| Cervical and Thoracic Myelopathy | 2021-2025 | 160 | CN 23 | 91.45 |
| Genital Health and Disease | 2021-2025 | 188 | CN 13 | 89.97 |
| Lung Cancer Research Studies | 2021-2025 | 698 | CN 141 | 92.36 |
| Kruppel-like factors research | 2021-2025 | 69 | CN 12 | 90.18 |
| Rheumatoid Arthritis Research and Therapies | 2021-2025 | 500 | CN 21 | 92.91 |
| Nausea and vomiting management | 2021-2025 | 113 | CN 19 | 88.84 |
| Viral-associated cancers and disorders | 2021-2025 | 313 | CN 60 | 89.70 |
| Aquaculture disease management and microbiota | 2021-2025 | 731 | CN 394 | 91.31 |
| Bone and Joint Diseases | 2021-2025 | 247 | CN 51 | 87.88 |
| Autophagy in Disease and Therapy | 2021-2025 | 524 | CN 257 | 87.71 |
| Histone Deacetylase Inhibitors Research | 2021-2025 | 337 | CN 83 | 87.30 |
| Protease and Inhibitor Mechanisms | 2021-2025 | 116 | CN 37 | 87.25 |
| Cancer Diagnosis and Treatment | 2021-2025 | 378 | CN 34 | 84.12 |
| Genetic factors in colorectal cancer | 2021-2025 | 784 | CN 67 | 88.04 |
| Spinal Fractures and Fixation Techniques | 2021-2025 | 727 | CN 93 | 90.43 |
| Neuropeptides and Animal Physiology | 2021-2025 | 236 | CN 34 | 86.40 |
| Tissue Engineering and Regenerative Medicine | 2021-2025 | 510 | CN 157 | 86.55 |
| Traditional Chinese Medicine Analysis | 2021-2025 | 186 | CN 170 | 86.08 |
| Anesthesia and Sedative Agents | 2021-2025 | 385 | CN 69 | 86.80 |
| Atherosclerosis and Cardiovascular Diseases | 2021-2025 | 408 | CN 74 | 85.72 |
| Single-cell and spatial transcriptomics | 2021-2025 | 959 | CN 260 | 85.66 |
| Urologic and reproductive health conditions | 2021-2025 | 351 | CN 15 | 85.10 |
| Hormonal Regulation and Hypertension | 2021-2025 | 660 | CN 66 | 83.88 |
| Cancer-related Molecular Pathways | 2021-2025 | 559 | CN 106 | 79.19 |
| Gastrointestinal Tumor Research and Treatment | 2021-2025 | 890 | CN 214 | 82.24 |
| Signaling Pathways in Disease | 2021-2025 | 168 | CN 59 | 75.56 |
| interferon and immune responses | 2021-2025 | 996 | CN 552 | 79.91 |
| Angiogenesis and VEGF in Cancer | 2021-2025 | 243 | CN 38 | 77.99 |
| Anesthesia and Neurotoxicity Research | 2021-2025 | 534 | CN 169 | 79.75 |
| Synthetic Organic Chemistry Methods | 2021-2025 | 421 | CN 198 | 81.49 |
| Inflammatory Biomarkers in Disease Prognosis | 2021-2025 | 687 | CN 289 | 76.88 |
| Metastasis and carcinoma case studies | 2021-2025 | 813 | CN 198 | 78.26 |
| Physiological and biochemical adaptations | 2021-2025 | 681 | CN 234 | 79.29 |
| Adipokines, Inflammation, and Metabolic Diseases | 2021-2025 | 984 | CN 196 | 74.97 |
| Acupuncture Treatment Research Studies | 2021-2025 | 514 | CN 345 | 77.27 |
| Fibroblast Growth Factor Research | 2021-2025 | 343 | CN 101 | 74.38 |
| Biochemical and Molecular Research | 2021-2025 | 463 | CN 92 | 73.50 |
| Soft tissue tumor case studies | 2021-2025 | 233 | CN 13 | 74.84 |
| Biological and pharmacological studies of plants | 2021-2025 | 159 | CN 135 | 73.91 |
| Heme Oxygenase-1 and Carbon Monoxide | 2021-2025 | 415 | CN 180 | 73.45 |
| Cytokine Signaling Pathways and Interactions | 2021-2025 | 694 | CN 210 | 71.19 |
| Bone Tumor Diagnosis and Treatments | 2021-2025 | 897 | CN 95 | 73.65 |
| Spinal Hematomas and Complications | 2021-2025 | 251 | CN 44 | 70.76 |
| Heat shock proteins research | 2021-2025 | 328 | CN 62 | 70.57 |
| Cholesterol and Lipid Metabolism | 2021-2025 | 374 | CN 78 | 69.00 |
| Molecular Biology Techniques and Applications | 2021-2025 | 983 | CN 266 | 67.67 |
| Tea Polyphenols and Effects | 2021-2025 | 910 | CN 697 | 71.43 |
| S100 Proteins and Annexins | 2021-2025 | 686 | CN 134 | 65.79 |
| Connexins and lens biology | 2021-2025 | 409 | CN 119 | 64.34 |
| Peroxisome Proliferator-Activated Receptors | 2021-2025 | 712 | CN 238 | 63.62 |
| Complementary and Alternative Medicine Studies | 2021-2025 | 905 | CN 128 | 64.32 |
| Microbial Metabolism and Applications | 2021-2025 | 694 | CN 308 | 62.10 |
| Skin and Cellular Biology Research | 2021-2025 | 623 | CN 80 | 59.35 |
| TGF-β signaling in diseases | 2021-2025 | 244 | CN 74 | 56.02 |
| Phytochemical Studies and Bioactivities | 2021-2025 | 340 | CN 207 | 55.21 |
| Sphingolipid Metabolism and Signaling | 2021-2025 | 827 | CN 120 | 55.17 |
| Biomarkers in Disease Mechanisms | 2021-2025 | 482 | CN 161 | 56.42 |
| Plant-based Medicinal Research | 2021-2025 | 555 | CN 389 | 52.69 |
| FOXO transcription factor regulation | 2021-2025 | 250 | CN 88 | 53.84 |
| Polyamine Metabolism and Applications | 2021-2025 | 928 | CN 381 | 47.68 |
| Collagen: Extraction and Characterization | 2021-2025 | 898 | CN 361 | 45.89 |
| Axon Guidance and Neuronal Signaling | 2021-2025 | 485 | CN 79 | 44.38 |
| Cell death mechanisms and regulation | 2021-2025 | 988 | CN 299 | 41.29 |
| Flavonoids in Medical Research | 2021-2025 | 531 | CN 235 | 41.82 |
| Pectus Deformity Diagnosis and Treatment | 2021-2025 | 238 | CN 18 | 36.18 |
| Plant-derived Lignans Synthesis and Bioactivity | 2021-2025 | 454 | CN 247 | 27.10 |